Key result
Elevated CpG and UpA in echovirus 7 RNA attenuate viral replication by enhancing ZAP binding.
May guide CpG/UpA recoding for enteroviral vaccine attenuation; leaves open in vivo efficacy and clinical translation.
We recently discovered that the OAS3/RNase L antiviral pathway is essential for restriction of CpG- and UpA-enriched viruses, in addition to the requirement for zinc finger antiviral protein (ZAP). The current study provides evidence for the specific dinucleotide and wider recognition contexts associated with virus recognition and attenuation. It further documents the association of ZAP and OAS3 and association with stress granules and a wider protein interactome that may mediate antiviral effects in different cellular compartments. The study provides a striking reconceptualization of the pathways associated with this aspect of antiviral defense.
No takes yet. Share an insight, caveat, or question.
Goonawardane et al. (2021) studied Echovirus 7 infection. Compositionally modified echovirus 7 replicons vs. Wild-type echovirus 7 replicon was evaluated on Viral replication (luciferase expression) and ZAP binding. Elevated frequencies of CpG and UpA dinucleotides in echovirus 7 RNA attenuated viral replication and enhanced specific binding to ZAP and OAS3, with CpG attenuation strongly influenced by flanking bases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: